glp-1 obesity drugs news today Study predicts 16 new may come to market What is the pipeline for
Description
The oral version must be taken in a special way - it should be taken after fasting overnight, with a small amount of water (no more than half a cup)
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Preliminary research indicates they may stop cravings even before people trying to quit feel them.
How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors
The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally
